Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Richard Ridinger is retiring after seven years as CEO, and current COO, Marc Funk, will take the position effective March 1, 2019.
January 30, 2019
By: Betsy Louda
Lonza announced that Richard Ridinger, current chief executive officer, has decided to retire from the company after seven successful years. Going forward, he intends to build a portfolio of non-executive positions in various companies. His successor as chief executive officer as of 1 March 2019 will be Marc Funk, currently chief operating officer of the Pharma & Biotech division.To ensure a seamless transition of leadership, Richard Ridinger will remain with the company until the end of April and will then be available to Lonza in an advisory capacity until the end of 2019. Albert M. Baehny, chairman of Lonza’s Board of Directors, said, “On behalf of the Board, I would like to thank Richard for his outstanding contribution to Lonza over the last seven years. Under his leadership, Lonza achieved a strategic, operational and financial turnaround, making it the world leader in its markets today. Richard’s achievement at Lonza’s main site in Visp (CH) deserves special mention. He took over a site with uncertain prospects and developed it into a pioneering industrial performance center. I look forward to working with him and Marc to ensure a seamless transition of leadership and wish Richard all the best for the future. I congratulate Marc Funk on his appointment. Since 2014 he has led Lonza’s fastest-growing division and built it to become the CDMO partner of choice for pharma and biologics companies. This experience has prepared him very well for his new role as Chief Executive Officer,” Richard Ridinger, chief executive officer, said, “I would like to express my personal appreciation to all the colleagues, customers and partners around the world for their valued contributions to Lonza’s success. It was a pleasure and a privilege to work with them. I wish my successor and long-standing colleague on the Executive Committee, Marc Funk, every success and personal fulfillment in the performance of his new duties.” Marc Funk, incoming chief executive officer, said, “I am honored to have been chosen as the new CEO of Lonza. Over the last few years, I have thoroughly enjoyed the challenge of advancing our Pharma & Biotech business and playing a key role in shaping its development into the world leadership position it enjoys today. As Lonza’s next CEO, I am committed to building on the company’s strong foundation and to driving forward the strategy across all our businesses along the Healthcare Continuum.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !